Transaction · 0001628280-26-066331

Welgus Howard G.

Welgus Howard G., DIR, reported an open-market or private sale at Arcutis Biotherapeutics, Inc. involving 4728.000000 shares for an estimated $127325.04. Reported holdings after the transaction were 35207.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SDIR
ARQTArcutis Biotherapeutics, Inc.
Trade date
Oct 15, 2026
Filing date
Oct 19, 2026
View on SEC Insider profile
Estimated value-$127kShares × reported price
Shares traded4.72k$26.93 per share
Holdings after35.2kDirect
% of reported position traded11.84%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 39,935 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

ARQT price since this filing

Daily closing prices, with the filing date and available return windows
ARQT · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -18.4%1w ago -15.0%1d ago -8.4%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001628280-26-066331
Common Stock
Transaction date
Oct 15, 2026
Filed Oct 19, 2026, 08:49 PM · 4d delay
Shares
4,728 sh
$26.93 per share
Estimated value
-$127k
Computed from shares × price
Holdings after
35,207 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership 10b5-1 Detected
Filing-only score

-4 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027.

  2. F2

    The option is fully vested.

Original filing · 0001628280-26-066331
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

ARQT